ANDREW GONZALES, M.S., R.PH.
Pharmacist in COVINGTON, Louisiana. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
ANDREW GONZALES, M.S., R.PH. filed 338 Medicare Part D claims in 2023 as a Pharmacist in COVINGTON, Louisiana, prescribing 0% generic.
- 338
- Part D claims, 2023
- 0%
- generic prescribing
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
ANDREW GONZALES, M.S., R.PH.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
338 Top 43% higher than 57% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about ANDREW GONZALES, M.S., R.PH.?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Louisiana
How Pharmacist compares to other specialties among Louisiana providers
Pharmacist share within Louisiana
Pharmacist is one of the more visible NUCC categories in Louisiana
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Pharmacist (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Pharmacist ABMS/AOA estimate
Est. board-certified rate (Pharmacist) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Pharmacist US NPIs
Specialty board-certified rate — Pharmacist estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
ANDREW GONZALES, M.S., R.PH. appears in the CMS NPPES registry as a Pharmacist provider holding M.S., R.PH. credentials at 880 US HWY 190, COVINGTON, LA, 70433, with a listed phone of (985) 893-9918. NPI 1396017208 was issued on 02/08/2012. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GONZALES most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 338 prescription claims written by this provider, covering 242 Medicare beneficiaries and totaling roughly $71K in drug spend, split 100% brand-name and 0% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Pharmacist is a high-volume specialty nationwide, with 290,447 enrolled providers across 56 states and an average of 135 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1396017208 |
|---|---|
| Specialty | Pharmacist |
| Credentials | M.S., R.PH. |
| Gender | Male |
| NPI Issued | 02/08/2012 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm ANDREW GONZALES, M.S., R.PH.'s current license status, disciplinary history, and board certifications with the Louisiana State Board of Medical Examiners in Louisiana before relying on this page for a clinical or care decision.
How we sourced this profile
Brand vs generic prescribing mix · Brand-heavy
100% brand-name claims vs 0% generic, on 338 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 338
- Total Day Supply
- 338
- Brand vs Generic
- 100% brand / 0% generic
- Brand Drug Cost
- $71K
- Generic Drug Cost
- $0
Patient Demographics
- Average Patient Age
- 73.3 years
- Avg HCC Risk Score
- 1.27
- Gender Split
- 55% female / 45% male
- Age Distribution
- <65: 12, 65-74: 130, 75-84: 87, 85+: 13
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What ANDREW GONZALES, M.S., R.PH. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Shingrix
Shingrix
131 claims
- Arexvy
Arexvy
99 claims
- Twinrix 43
Twinrix
43 claims
| Drug | Claims |
|---|---|
| Shingrix Varicella-Zoster Ge/As01b/Pf | 131 |
| Arexvy Rsvpref3 Antigen/As01e/Pf | 99 |
| Twinrix Hepatitis A And B Vaccine/Pf | 43 |
| Boostrix Tdap "Diphth | N/A |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pharmacist Overview
How ANDREW GONZALES, M.S., R.PH. fits within the Pharmacist landscape nationally.
ANDREW GONZALES, M.S., R.PH.'s 338 claims are above the specialty average of 135.
Nearby Pharmacist Providers in Louisiana
Other clinicians with the same primary specialty enrolled in Louisiana, drawn from the same CMS NPPES roster as GONZALES.
Compare Pharmacist nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Louisiana
Frequently Asked Questions
What is ANDREW GONZALES, M.S., R.PH.'s specialty? ▼
How much does ANDREW GONZALES, M.S., R.PH. prescribe under Medicare Part D? ▼
Where is ANDREW GONZALES, M.S., R.PH. located? ▼
What is ANDREW GONZALES, M.S., R.PH.'s NPI number? ▼
Does ANDREW GONZALES, M.S., R.PH. prescribe more brand-name or generic drugs? ▼
How many Pharmacist providers are there in the US? ▼
What drugs does ANDREW GONZALES, M.S., R.PH. prescribe most often? ▼
Does ANDREW GONZALES, M.S., R.PH. accept Medicare? ▼
How can I verify ANDREW GONZALES, M.S., R.PH.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology